Publication | Closed Access

Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor

OncologyMedicinePharmacologyColorectal CancerNmda ReceptorColorectal Cancer CellsAnti-cancer AgentCancer BiologyCell BiologyCancer Research